Multicenter comparative analysis of FRED-X, pipeline shield, and surpass evolve in treating intracranial aneurysms.
Publication/Presentation Date
10-25-2025
Abstract
BackgroundIn recent years, newer flow diverters have been developed with surface modification and varying wire densities. Our study evaluated outcomes among three newer generation flow diverter devices, FRED-X, PED Shield and Surpass Evolve.MethodsThis was a retrospective study of patients from five participating institutions across the United States. Patients who underwent flow diversion of intracranial aneurysms using the FRED-X, PED Shield or Surpass Evolve between February 2022 and September 2024 were included. Outcomes of interest were technical success, angiographic occlusion and in-stent stenosis (ISS).ResultsAmong 447 patients with 452 aneurysms, adjunct device use was highest with Surpass Evolve (36.4%) versus PED Shield (15.7%) and FRED-X (6.4%) (
First Page
15910199251384687
Last Page
15910199251384687
ISSN
2385-2011
Published In/Presented At
Roy, J. M., Musmar, B., Karadimas, S., Lan, M., Koduri, S., Momin, A., McNulty, A., Paul, A., Zhang, Y., Puri, A. S., Singh, J., Kuhn, A. L., Jaikumar, V., Lim, J., Levy, E., Gooch, M. R., Jabbour, P., Rosenwasser, R. H., & Tjoumakaris, S. I. (2025). Multicenter comparative analysis of FRED-X, pipeline shield, and surpass evolve in treating intracranial aneurysms. Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences, 15910199251384687. Advance online publication. https://doi.org/10.1177/15910199251384687
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
41137638
Department(s)
Administration and Leadership
Document Type
Article